These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 18084248)

  • 1. TROP2: a novel prognostic marker in squamous cell carcinoma of the oral cavity.
    Fong D; Spizzo G; Gostner JM; Gastl G; Moser P; Krammel C; Gerhard S; Rasse M; Laimer K
    Mod Pathol; 2008 Feb; 21(2):186-91. PubMed ID: 18084248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue mechanics and expression of TROP2 in oral squamous cell carcinoma with varying differentiation.
    Zhang B; Gao S; Li R; Li Y; Cao R; Cheng J; Guo Y; Wang E; Huang Y; Zhang K
    BMC Cancer; 2020 Aug; 20(1):815. PubMed ID: 32854652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of TROP2 is correlated with poor prognosis of oral squamous cell carcinoma.
    Tang G; Tang Q; Jia L; Xia S; Li J; Chen Y; Li H; Ding X; Wang F; Hou D; Kuai X; Feng Z; Fan Y
    Pathol Res Pract; 2018 Oct; 214(10):1606-1612. PubMed ID: 30098828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TROP2 expression as prognostic marker for gastric carcinoma.
    Mühlmann G; Spizzo G; Gostner J; Zitt M; Maier H; Moser P; Gastl G; Zitt M; Müller HM; Margreiter R; Ofner D; Fong D
    J Clin Pathol; 2009 Feb; 62(2):152-8. PubMed ID: 18930986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EpCAM expression in squamous cell carcinoma of the oral cavity: frequency and relationship to clinicopathologic features.
    Laimer K; Fong D; Gastl G; Obrist P; Kloss F; Tuli T; Gassner R; Rasse M; Norer B; Spizzo G
    Oral Oncol; 2008 Jan; 44(1):72-7. PubMed ID: 17418618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of TROP2 correlates with poor prognosis in pancreatic cancer.
    Fong D; Moser P; Krammel C; Gostner JM; Margreiter R; Mitterer M; Gastl G; Spizzo G
    Br J Cancer; 2008 Oct; 99(8):1290-5. PubMed ID: 18813308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of TROP2 in human nasopharyngeal carcinoma.
    Guan GF; Zhang DJ; Wen LJ; Yu DJ; Zhao Y; Zhu L; Guo YY; Zheng Y
    Int J Clin Exp Pathol; 2015; 8(9):10995-1004. PubMed ID: 26617817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of TROP2 expression in patients with gallbladder cancer.
    Chen MB; Wu HF; Zhan Y; Fu XL; Wang AK; Wang LS; Lei HM
    Tumour Biol; 2014 Nov; 35(11):11565-9. PubMed ID: 25135430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential therapeutic target and independent prognostic marker of TROP2 in laryngeal squamous cell carcinoma.
    Wu H; Xu H; Zhang S; Wang X; Zhu H; Zhang H; Zhu J; Huang J
    Head Neck; 2013 Oct; 35(10):1373-8. PubMed ID: 22987366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TROP2 overexpression promotes proliferation and invasion of lung adenocarcinoma cells.
    Li Z; Jiang X; Zhang W
    Biochem Biophys Res Commun; 2016 Jan; 470(1):197-204. PubMed ID: 26773504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trophoblast cell surface antigen 2 expression predicts outcome in oral squamous cell carcinomas.
    Dourado MR; Machado RA; Paranaíba LMR; González-Arriagada WA; da Silva SD; Sawazaki-Calone Í; Graner E; Salo T; Coletta RD
    Oral Dis; 2022 May; 28(4):1085-1093. PubMed ID: 33615627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High EGFR expression predicts poor prognosis in patients with squamous cell carcinoma of the oral cavity and oropharynx: a TMA-based immunohistochemical analysis.
    Laimer K; Spizzo G; Gastl G; Obrist P; Brunhuber T; Fong D; Barbieri V; Jank S; Doppler W; Rasse M; Norer B
    Oral Oncol; 2007 Feb; 43(2):193-8. PubMed ID: 16854613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bax expression measured by AQUAnalysis is an independent prognostic marker in oral squamous cell carcinoma.
    Bose P; Klimowicz AC; Kornaga E; Petrillo SK; Matthews TW; Chandarana S; Magliocco AM; Brockton NT; Dort JC
    BMC Cancer; 2012 Aug; 12():332. PubMed ID: 22852863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significance of EpCAM and TROP2 expression in non-small cell lung cancer.
    Pak MG; Shin DH; Lee CH; Lee MK
    World J Surg Oncol; 2012 Apr; 10():53. PubMed ID: 22482828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of Spatially Heterogeneous Trop-2 Expression on Prognosis in Oral Squamous Cell Carcinoma.
    Erber R; Spoerl S; Mamilos A; Krupar R; Hartmann A; Ruebner M; Taxis J; Wittenberg M; Reichert TE; Spanier G; Spoerl S
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin D1 overexpression and poor clinical outcomes in Taiwanese oral cavity squamous cell carcinoma.
    Huang SF; Cheng SD; Chuang WY; Chen IH; Liao CT; Wang HM; Hsieh LL
    World J Surg Oncol; 2012 Feb; 10():40. PubMed ID: 22336657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TROP2 in colorectal carcinoma: associations with histopathology, molecular phenotype, and patient prognosis.
    Foersch S; Schmitt M; Litmeyer AS; Tschurtschenthaler M; Gress T; Bartsch DK; Pfarr N; Steiger K; Denkert C; Jesinghaus M
    J Pathol Clin Res; 2024 Sep; 10(5):e12394. PubMed ID: 39177576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in LC3B expression and prognostic implications in oropharyngeal and oral cavity squamous cell carcinoma patients.
    Lai K; Matthews S; Wilmott JS; Killingsworth MC; Yong JL; Caixeiro NJ; Wykes J; Samakeh A; Forstner D; Lee M; McGuinness J; Niles N; Hong A; Ebrahimi A; Lee CS
    BMC Cancer; 2018 Jun; 18(1):624. PubMed ID: 29859041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.